Dr. Paul Gratzer is the inventor of the patented decellularization technology and co-founder of DeCell Technologies Inc. His research has been focused on soft tissue regeneration and decellularization for over 25 years. He is a licensed Professional Engineer and an Associate Professor in the School of Biomedical Engineering at Dalhousie University in Halifax, NS with cross-appointments in the Departments of Surgery and Process Engineering and Applied Science. Dr. Gratzer’s research is frequently cited and he has been invited to write multiple book chapters on decellularization processes as applied to tissue engineering. He is a member of the editorial board for the Open Biomedical Engineering Journal, is an active reviewer for many prominent biomedical journals, has been involved with national and international scientific societies and participates as an expert on many research funding agency committees (Natural Sciences and Engineering Council of Canada, Canadian Institutes of Health Research, Canadian National Research Chairs, Medical Research Council (UK)) and a technical advisor for the Canadian Blood Services in Tissue Banking. Dr. Gratzer’s work has been recognized with the 2015 Discovery Award for Innovation and Best Presenting Company: Early Stage Growth at the 2014 Atlantic Venture Forum.